Providing market research reports, industry analysis, company profiles and country reports for strategic planning, competitive intelligence, marketing and business research.
Search for Market Research Reports:    

Netherlands Pharmaceuticals and Healthcare Report Q3 2007

Published by: Business Monitor International

Published: Nov. 6, 2007 - 71 Pages


Table of Contents


Executive Summary
Netherlands Pharmaceuticals & Healthcare Industry SWOT
Business Environment Rankings
Table: Business Environment Rankings
Business Environment Ranking
Economics - Long-Term Risk
Politics - Long-Term Risk
Regulatory Barriers
Domestic Sector Threat
Market Growth Potential
Market Size Ranking
Regional Review
Market Summary
Regulatory Regime
Intellectual Property Developments
Pricing And Reimbursement
OTC Medicines
Industry Developments
Healthcare Sector
Healthcare Insurance
Key Points: Dutch Health Insurance Act January 1 2006
Health Profile
Pharmaceuticals Sector
Recent Domestic Companies’ Activities
Recent Foreign Companies’ Activities
R&D Sector
Recent Company Developments In The Field Of R&D Include:
Industry Forecast Scenario
Overall Market Forecast
Table: The Netherlands Drug Market Forecast Indicators
Key Growth Factors - Industry
Table: Netherlands Health Expenditure Indicators
Key Growth Factors - Macroeconomic
Table: Netherlands - Macroeconomic Forecasts
Prescription Market Forecast
Table: The Netherlands Prescription Drug Market Forecast Indicators
Over-The-Counter (OTC) Market Forecast
Table: The Netherlands OTC Drugs Market Forecast Indicators
Generics And Branded Market Forecasts
Table: The Netherlands Generics And Branded Market Forecast Indicators
Export/Import Forecasts
Table: The Netherlands Sectoral Trade Forecast Indicators
Key Risks To BMI’s Forecast Scenario
Competitive Landscape
Company Profiles
Leading Multinational Manufacturers
Merck & Co
Pfizer
GlaxoSmithKline (GSK)
Sanofi-Aventis
Novartis
Company Profiles: Indigenous Manufacturers
Akzo Nobel
DSM
Qiagen
Pharming Group
Crucell
BMI Forecast Modelling
How We Generate Our Industry Forecasts
Technical Process
Pharmaceutical Industry
Sources


Abstract

Drug expenditure in the Netherlands stood at US$5.78bn in 2006 and BMI forecasts that it will expand ata Compound Annual Growth Rate CAGR) of 2.3% between 2006-2011. As examined in BMI’s Q307Netherlands Pharmaceuticals & Healthcare Report such growth is modest by regional standards and isbelow GDP growth, suggesting that government cost-containment initiatives are having the desiredimpact.


Get Full Details About This Report >>
US: 800.298.5699
Int'l: +1.240.747.3093
Buy this Report
Price and Delivery Options
Search Inside Report


 

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

 

© MarketResearch.com 2008